Zobrazeno 1 - 10
of 161
pro vyhledávání: '"M Elaine Husni"'
Autor:
Joseph F Merola, Philip J Mease, Dafna D Gladman, M Elaine Husni, Nadine Goldammer, Jason Coarse, William Tillett, Vanessa Taieb, Jeremy Lambert, Barbara Ink
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objectives To assess impact of bimekizumab treatment on patient-reported outcomes and health-related quality of life (HRQoL) in patients with active psoriatic arthritis (PsA), using 16-week data from two phase 3 studies.Methods BE OPTIMAL (NCT0389520
Externí odkaz:
https://doaj.org/article/6b47e439da8445b083e973aca1ddd188
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240416 (2020)
BackgroundDespite treatment advances for inflammatory arthritis, a significant amount of patients fail to achieve remission. Other modifiable factors such as diet, physical activity and environmental exposures may be an important area of focus to hel
Externí odkaz:
https://doaj.org/article/66c73f48492c42c09521aae6c93ef29d
Autor:
M. Elaine Husni, Atul Deodhar, Sergio Schwartzman, Soumya D. Chakravarty, Elizabeth C. Hsia, Jocelyn H. Leu, Yiying Zhou, Kim H. Lo, Arthur Kavanaugh
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background Intravenous (IV) golimumab, a TNFi, is approved for treating rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). We analyzed pooled safety results from three phase 3 IV golimumab trials in these
Externí odkaz:
https://doaj.org/article/09e6a686072943d2b8e0568dc745d31c
Autor:
Philip Mease, M. Elaine Husni, Soumya D. Chakravarty, Shelly Kafka, Dennis Parenti, Lilianne Kim, Kim Hung Lo, Elizabeth C. Hsia, Arthur Kavanaugh
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 11, Pp 640-647 (2020)
Objective To evaluate whether intravenous (IV) golimumab produces improvements in skin and nail symptoms that are concomitant with improvements in quality of life (QoL) and joint symptoms in patients with psoriatic arthritis. Methods Patients were ra
Externí odkaz:
https://doaj.org/article/16791a817ad3468185cd6445bb00e287
Autor:
Philip Mease, M. Elaine Husni, Shelly Kafka, Soumya D. Chakravarty, Diane D. Harrison, Kim Hung Lo, Stephen Xu, Elizabeth C. Hsia, Arthur Kavanaugh
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background In the GO-VIBRANT trial of intravenous golimumab in psoriatic arthritis (PsA), golimumab significantly inhibited radiographic progression. In post hoc analyses, we evaluated changes in total PsA-modified Sharp/van der Heijde score
Externí odkaz:
https://doaj.org/article/945104ccbdc445aca228892252650489
Publikováno v:
Rheumatic Disease Clinics of North America. 49:179-191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::631b67c57522279d42fc930d8656b3ce
https://doi.org/10.1016/j.rdc.2022.08.006
https://doi.org/10.1016/j.rdc.2022.08.006
Autor:
Philip Helliwell, Laura C. Coates, Oliver FitzGerald, Peter Nash, Enrique R. Soriano, M. Elaine Husni, Ming-Ann Hsu, Keith S. Kanik, Thijs Hendrikx, Joseph Wu, Elizabeth Kudlacz
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-13 (2018)
Abstract Background The multiple disease domains affected in psoriatic arthritis (PsA) may make composite endpoints appropriate for assessing changes in disease activity over time. Tofacitinib is an oral Janus kinase inhibitor for the treatment of Ps
Externí odkaz:
https://doaj.org/article/993f00951db4496f85d699f96eba7244
Autor:
Unnikrishnan M. Chandrasekharan, Zeneng Wang, Yuping Wu, W. H. Wilson Tang, Stanley L. Hazen, Sihe Wang, M. Elaine Husni
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-12 (2018)
Abstract Background Rheumatoid arthritis (RA) patients are at high risk of developing cardiovascular disease (CVD). In RA, chronic inflammation may lead to endothelial dysfunction, an early indicator of CVD, owing to diminished nitric oxide (NO) prod
Externí odkaz:
https://doaj.org/article/a76a76ce64f9448085fc8a2eaba90b06
Autor:
M. Elaine Husni, Anthony Fernandez, Brett Hauber, Rakesh Singh, Joshua Posner, Jessie Sutphin, Arijit Ganguli
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Abstract Background The perceived bother of skin and joint-related manifestations of psoriatic disease may differ among patients, rheumatologists, and dermatologists. This study identified and compared the patient and dermatologist/rheumatologist-per
Externí odkaz:
https://doaj.org/article/4bdec43dec464edc9ad1c502eccd1591
Autor:
Vibeke Strand, M. Elaine Husni, Keith A. Betts, Yan Song, Rakesh Singh, Jenny Griffith, Marci Beppu, Jing Zhao, Arijit Ganguli
Publikováno v:
BMC Rheumatology, Vol 2, Iss 1, Pp 1-8 (2018)
Abstract Background Multiple targeted immunomodulators (TIMs) for psoriatic arthritis (PsA) treatment are available, but limited studies have directly compared these agents. This study indirectly compared the efficacy of TNF-α, interleukins, and pho
Externí odkaz:
https://doaj.org/article/c4f6e0784a0c42ec9bcbffcff207649d